Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $6.97 million. The enterprise value is -$3.34 million.

Market Cap	6.97M
Enterprise Value	-3.34M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

MBRX has 2.84 million shares outstanding. The number of shares has increased by 16.88% in one year.

Shares Outstanding	2.84M
Shares Change (YoY)	+16.88%
Shares Change (QoQ)	+3.13%
Owned by Insiders (%)	3.28%
Owned by Institutions (%)	5.55%
Float	2.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.35
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.03.

Current Ratio	2.39
Quick Ratio	1.89
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.82% and return on invested capital (ROIC) is -58.95%.

Return on Equity (ROE)	-86.82%
Return on Assets (ROA)	-47.68%
Return on Capital (ROIC)	-58.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.40M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.04% in the last 52 weeks. The beta is 1.86, so MBRX's price volatility has been higher than the market average.

Beta (5Y)	1.86
52-Week Price Change	-68.04%
50-Day Moving Average	2.50
200-Day Moving Average	4.57
Relative Strength Index (RSI)	46.00
Average Volume (20 Days)	21,448

Short Selling Information

The latest short interest is 171,524, so 6.03% of the outstanding shares have been sold short.

Short Interest	171,524
Short Previous Month	170,928
Short % of Shares Out	6.03%
Short % of Float	6.63%
Short Ratio (days to cover)	3.82

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.73M
Pretax Income	-26.82M
Net Income	-25.17M
EBITDA	-27.60M
EBIT	-27.73M
Earnings Per Share (EPS)	-$11.17

Full Income Statement

Balance Sheet

The company has $10.85 million in cash and $532,000 in debt, giving a net cash position of $10.31 million or $3.63 per share.

Cash & Cash Equivalents	10.85M
Total Debt	532,000
Net Cash	10.31M
Net Cash Per Share	$3.63
Equity (Book Value)	17.71M
Book Value Per Share	6.91
Working Capital	7.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.62 million and capital expenditures -$122,000, giving a free cash flow of -$25.75 million.

Operating Cash Flow	-25.62M
Capital Expenditures	-122,000
Free Cash Flow	-25.75M
FCF Per Share	-$9.05

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.88%
Shareholder Yield	-16.88%
Earnings Yield	-361.12%
FCF Yield	-369.43%

Analyst Forecast

The average price target for MBRX is $35.00, which is 1,328.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$35.00
Price Target Difference	1,328.57%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Mar 22, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a